Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
IMPORTANT: Beginning at 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
TRANSIT ALERT: Major cuts to bus, subway, and rail may affect travel to and from our campuses. Read full update.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Temple University Hospital’s Advanced Pulmonary Hypertension, Right Heart Failure & CTEPH/PTE Heart Program Achieves Twin Milestones
Posted August 21, 2025Temple performed its 500th pulmonary thromboendarterectomy and 500th balloon pulmonary angioplasty, two treatments for patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Read MorePhiladelphia Business Journal Highlights Temple Health’s Unprecedented Financial Pressures
Posted August 21, 2025The Philadelphia Business Journal reported on the unprecedented financial pressures Temple Health will face as a result of H.R. 1, the Reconciliation Bill of 2025 and related federal Medicaid cuts.
Read More